Prenetics Global Limited (PRE)
Company Description
Prenetics Global Limited operates as a diagnostics and genetic testing company in Hong Kong and the United Kingdom.
Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring device that offers COVID-19 testing solutions for professional use and home use.
The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; ACTOnco, a comprehensive test that helps clinicians choose the optimal treatment for all major solid tumors; ACTDrug+, a screening test that checks for 40 cancer genes to map drug options and provide treatment strategy options; ACTLung, a test focused on biomarkers associated with lung cancer for targeted therapy; ACTFusion, a test that decodes 13 fusion genes and more than 350 transcripts to map drug options; and ACTCerebra, a genomic profiling service for solid tumors.
It also offers ACTMonitor, a test that analyzes 50 forms of circulating tumor DNA in the bloodstream; and ACT Risk, a screening of 67 cancer genes associated with 9 common hereditary cancers and 11 cancer syndromes.
Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.
Country | Hong Kong |
Founded | 2014 |
Industry | Diagnostics & Research |
Sector | Healthcare |
Employees | 400 |
CEO | Sheng Wu Yeung |
Contact Details
Address: 7/f, K11 Atelier, 728 King's Road Quarry Bay, K3 000000 Hong Kong | |
Phone | (852) 2210-7188 |
Website | prenetics.com |
Stock Details
Ticker Symbol | PRE |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001876431 |
CUSIP Number | G72245106 |
ISIN Number | KYG722451229 |
SIC Code | 3826 |
Key Executives
Name | Position |
---|---|
Sheng Wu Yeung | Co-Founder and Chief Executive Officer |
Dr. Chi Hung Tzang Ph.D. | Co-Founder, Chief Scientific Officer and Member of Scientific Advisory Board |
Hoi Chun Lo | Chief Financial Officer |
Dr. Yung Ho Wong DPHIL | Chief Technology Officer |
Yvonne L. Wong | Chief Corporate Development Officer |
Samantha Kwok | Vice President People and Culture |
Dr. Senthil Sundaram M.D. | Chief Clinical Officer |
Avrom Boris Lasarow | Chief Executive Officer of EMEA |
Dr. Shih-Chang Ong M.D. | Chief Medical Officer and Member of Scientific Advisory Board |
Joel Neoh | Chief Consumer Officer and MD for CircleDNA |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Feb 16, 2024 | EFFECT | Notice of Effectiveness |
Feb 16, 2024 | 424B3 | Prospectus |
Feb 5, 2024 | F-3/A | Filing |
Feb 5, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Jan 26, 2024 | UPLOAD | Filing |
Jan 17, 2024 | F-3 | Filing |
Nov 30, 2023 | 6-K | Report of foreign issuer |
Nov 27, 2023 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Nov 20, 2023 | 6-K | Report of foreign issuer |
Nov 13, 2023 | 6-K | Report of foreign issuer |